GeneLink (OTCPK:GNLK.Q) - Stock Price, News & Analysis

GNLK.Q Stock Overview

Offers 12-gene DNA assessment services. More details

GNLK.Q fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($265)

Shares are highly illiquid

GeneLink, Inc. Competitors

eFFECTOR Therapeutics

OTCPK:EFTR

US$940.0

DermTech

OTCPK:DMTK.Q

US$35.0

Genocea Biosciences

OTCPK:GNCA.Q

US$5.9k

ObsEva

OTCPK:OBSE.F

US$11.7k

Price History & Performance

Summary of all time highs, changes and price drops for GeneLink
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.00001
52 Week Low	US$0.000001
Beta	0
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	0%
33 Year Change	0%
5 Year Change	-99.75%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	GNLK.Q	US Biotechs	US Market
7D	0%	4.3%	1.6%
1Y	0%	18.8%	32.3%

Return vs Industry: GNLK.Q underperformed the US Biotechs industry which returned 18% over the past year.

Return vs Market: GNLK.Q underperformed the US Market which returned 32.4% over the past year.

Price Volatility

Is GNLK.Q's price volatile compared to industry and market?
GNLK.Q volatility
GNLK.Q Average Weekly Movement	n/a
Biotechs Industry Average Movement	9.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	3.1%

Stable Share Price: GNLK.Q's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine GNLK.Q's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1994	n/a	Bernard Kasten	www.genelinkbio.com

GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products.

GeneLink, Inc. Fundamentals Summary

How do GeneLink's earnings and revenue compare to its market cap?
GNLK.Q fundamental statistics
Market cap	US$265.00
Earnings (TTM)	-US$2.23m
Revenue (TTM)	US$1.58m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is GNLK.Q overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GNLK.Q income statement (TTM)
Revenue	US$1.58m
Cost of Revenue	US$1.27m
Gross Profit	US$306.40k
Other Expenses	US$2.53m
Earnings	-US$2.23m

Last Reported Earnings

Sep 30, 2013

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did GNLK.Q perform over the long term?

See historical performance and comparison